Independent US Healthcare Provider Directory & Public Medical Database Patient Guides
T-MedInfo US Healthcare Directory

Dr. Kush Sachdeva , MD

Specialist • Vineland, NJ

Active NPI 1750372686 Individual Practitioner Male Practitioner Accepts Medicare assignment Telehealth (some services)
Practice location in NPPES

1505 W Sherman Ave, Suite 101
Vineland, NJ 083606912

Call 8566969550 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

1505 W Sherman Ave
Suite 101

Vineland, NJ 083606912

Telephone 8566969550
Fax 8566911686
Before You Book

Paying without insurance? Prepare a cost-estimate request

Ask about interpreters and office accessibility

Organization at the Same NPPES Address or Phone
South Jersey Radiation Oncology P.c. Facility NPI 1871593426

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Other Listings in Public Data

CMS Doctors and Clinicians lists 2 distinct group names: Shore Memorial Hospital; Southern Oncology Hematology Assoc. See the list

Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.

Listings do not confirm current availability, employment or a shared ownership network.

Medicare Profile & Education

Source: CMS Doctors and Clinicians National Downloadable File

Graduation Year

1990

What Public CMS Data Show

These CMS figures cover limited populations and published records; they are not quality ratings or medical advice.

Specialist: NPPES taxonomy is a reported classification, not proof of board certification.

Medicare patients

510 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

It gives a sense of how many people with Medicare this clinician treated that year.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $1,308,562 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $1,039,166 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

The gap between the allowed amount and this number is roughly what patients and their other insurance paid.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

964 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$2,456,784 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

It shows the total spending on drugs this clinician prescribed, not what any one patient paid.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $2,821.85 across 152 records.

By nature of payment

  • Food and Beverage: $2,698.80 across 150 records.
  • Education: $123.05 across 2 records.

Reporting-company totals (3 largest of 48)

  • Novartis Pharmaceuticals Corporation: $259.57 across 13 records.
  • GlaxoSmithKline, LLC.: $204.84 across 13 records.
  • Daiichi Sankyo Inc.: $184.51 across 10 records.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

Years since graduation

36 years (graduated 1990)

CMS Doctors and Clinicians data list 1990 as the year this clinician finished professional school.

It tells you roughly how long ago the clinician finished school.

What this does not show: Years since graduation

It is not the number of years in practice, and more years does not mean better care.

Source: CMS Doctors and Clinicians National Downloadable File.

NPI first issued

2005

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Accepts Medicare assignment

CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.

With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

Telehealth (some services)

Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.

You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.

What this does not show: Telehealth (some services)

It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Sachdeva has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Sachdeva as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

Medicare pays for these items and services only when they are ordered by an eligible clinician.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Vineland and New Jersey

Billing and prescribing volume is not a quality rating.

Medicare Part B services

More Medicare Part B services than 95% of clinicians listed under Specialist in New Jersey (2024, 454 clinicians with data). Median for this group: 1,216. Middle half: 379 to 3,335.

Too few clinicians listed under Specialist in Vineland have Medicare Part B data for 2024 to compare.

Medicare-allowed amount

A higher Medicare-allowed amount than 95% of clinicians listed under Specialist in New Jersey (2024, 454 clinicians with data). Median for this group: $102,518. Middle half: $34,749 to $219,553.

Too few clinicians listed under Specialist in Vineland have Medicare Part B data for 2024 to compare.

Paid by Medicare

A higher Medicare payment amount than 95% of clinicians listed under Specialist in New Jersey (2024, 454 clinicians with data). Median for this group: $77,614. Middle half: $27,413 to $166,417.

Too few clinicians listed under Specialist in Vineland have Medicare Part B data for 2024 to compare.

Medicare Part D prescriptions

Close to the middle for clinicians listed under Specialist in New Jersey (2024, 365 clinicians with data). Median for this group: 645. Middle half: 134 to 1,745.

Too few clinicians listed under Specialist in Vineland have Medicare Part D data for 2024 to compare.

Part D drug cost

A higher Part D drug cost than 95% of clinicians listed under Specialist in New Jersey (2024, 365 clinicians with data). Median for this group: $63,715. Middle half: $4,163 to $333,079.

Too few clinicians listed under Specialist in Vineland have Medicare Part D data for 2024 to compare.

20 active clinicians are listed under Specialist with a practice address in Vineland, NJ (1,641 in New Jersey).

Addresses are self-reported to NPPES and may be out of date.

Telehealth indicator in Vineland

15% of these 20 clinicians have the CMS telehealth indicator.

45% of these 20 clinicians are listed by CMS as accepting Medicare assignment.

CMS data by year

Changes may reflect reporting, coverage or privacy limits, not changes in care quality.

  • Medicare Part B services

    Medicare Part B services decreased 16% from 125,294 in 2020 to 105,034 in 2024.

    • 2020: 125,294
    • 2021: 151,697
    • 2022: 60,561
    • 2023: 69,488
    • 2024: 105,034

  • Medicare-allowed amount

    Medicare-allowed amount decreased 16% from $1,563,871 in 2020 to $1,308,562 in 2024.

    • 2020: $1,563,871
    • 2021: $1,290,229
    • 2022: $1,173,221
    • 2023: $1,117,813
    • 2024: $1,308,562

  • Paid by Medicare

    Paid by Medicare decreased 16% from $1,244,360 in 2020 to $1,039,166 in 2024.

    • 2020: $1,244,360
    • 2021: $1,028,014
    • 2022: $931,397
    • 2023: $888,608
    • 2024: $1,039,166

  • Medicare Part D prescriptions

    Medicare Part D prescriptions varied from year to year: 742 in 2020 and 746 in 2024.

    • 2020: 742
    • 2021: 562
    • 2022: 406
    • 2023: 501
    • 2024: 746

  • 30-day fills

    30-day fills decreased 11% from 1,088 in 2020 to 964 in 2024.

    • 2020: 1,088
    • 2021: 876
    • 2022: 585
    • 2023: 661
    • 2024: 964

  • Part D drug cost

    Part D drug cost increased 114% from $1,149,989 in 2020 to $2,456,784 in 2024.

    • 2020: $1,149,989
    • 2021: $1,336,252
    • 2022: $1,826,513
    • 2023: $1,618,572
    • 2024: $2,456,784

  • Industry payments (Open Payments)

    Industry payments (Open Payments) increased 86% from $1,515.82 in 2021 to $2,821.85 in 2025.

    • 2021: $1,515.82
    • 2022: $1,483.45
    • 2023: $5,737.72
    • 2024: $2,788.15
    • 2025: $2,821.85

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): 152 records totaling $2,821.85.

Manufacturer Payment Nature Product Type Amount ($)
Incyte Corporation
Education
Cash or cash equivalent
 — General $99.95
AVYXA PHARMA, LLC
Food and Beverage
In-kind items and services
 LUTRATE DEPOT General $44.31
Invivyd Inc
Food and Beverage
In-kind items and services
 PEMGARDA General $33.41
Bristol Myers Squibb Company
Food and Beverage
Cash or cash equivalent
 OPDUALAG General $31.62
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
 Fabhalta General $30.41
Daiichi Sankyo Inc.
Food and Beverage
In-kind items and services
 Enhertu General $29.78
Astellas Pharma US Inc
Food and Beverage
In-kind items and services
 Padcev General $28.75
Bayer Healthcare Pharmaceuticals Inc.
Food and Beverage
In-kind items and services
 Nubeqa General $28.47
Invivyd Inc
Food and Beverage
In-kind items and services
 PEMGARDA General $27.95
Daiichi Sankyo Inc.
Food and Beverage
In-kind items and services
 Enhertu General $26.96
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
 Fabhalta General $25.84
Daiichi Sankyo Inc.
Food and Beverage
In-kind items and services
 Enhertu General $25.68
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
 KISQALI General $25.55
Bristol Myers Squibb Company
Food and Beverage
Cash or cash equivalent
 OPDUALAG General $24.87
Novocure Inc.
Food and Beverage
Cash or cash equivalent
 Optune Lua (NovoTTF-200T) General $24.38
AstraZeneca Pharmaceuticals LP
Food and Beverage
In-kind items and services
 IMFINZI General $24.16
Daiichi Sankyo Inc.
Food and Beverage
In-kind items and services
 DATROWAY General $24.06
GlaxoSmithKline, LLC.
Food and Beverage
In-kind items and services
 BLENREP General $23.54
Pharmacosmos Therapeutics Inc.
Food and Beverage
In-kind items and services
 MONOFERRIC General $23.24
GlaxoSmithKline, LLC.
Food and Beverage
In-kind items and services
 OJJAARA General $23.12
AstraZeneca Pharmaceuticals LP
Education
In-kind items and services
 — General $23.10
Kite Pharma, Inc.
Food and Beverage
In-kind items and services
 Yescarta General $22.79
Astellas Pharma US Inc
Food and Beverage
In-kind items and services
 Padcev General $22.58
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
 KISQALI General $21.63
Novartis Pharmaceuticals Corporation
Food and Beverage
In-kind items and services
 KISQALI General $21.58

(top 25 shown)

Source: CMS Open Payments, program year 2025, released June 30, 2026.

A reported payment does not necessarily indicate wrongdoing; clinicians can dispute a record with CMS.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
J1439 Injection, ferric carboxymaltose, 1 mg
63,750 54 $3.00 $1.09
J9271 Injection, pembrolizumab, 1 mg
11,200 19 $119.91 $56.36
J0897 Injection, denosumab, 1 mg
5,700 30 $50.00 $25.68
J1449 Injection, eflapegrastim-xnst, 0.1 mg
4,884 18 $100.00 $26.39
J9267 Injection, paclitaxel, 1 mg
4,744 12 $2.00 $0.10
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
2,840 23 $50.00 $7.89
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
2,660 17 $25.00 $7.36
J1100 Injection, dexamethasone sodium phosphate, 1 mg
1,860 57 $1.02 $0.11
J2405 Injection, ondansetron hydrochloride, per 1 mg
1,380 26 $2.00 $0.09
J2469 Injection, palonosetron hcl, 25 mcg
1,100 34 $51.09 $0.88
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
910 265 $29.89 $7.61
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
559 230 $199.28 $140.28
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
499 234 $148.56 $100.04
96375 Injection of additional new drug or substance into vein
441 71 $77.62 $17.19
96372 Injection of drug or substance under skin or into muscle
429 112 $99.01 $15.84
96413 Administration of chemotherapy into vein, 1 hour or less
319 80 $301.13 $145.79
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
231 47 $95.04 $31.77
96415 Administration of chemotherapy into vein, each additional hour
154 32 $200.00 $31.03
J9045 Injection, carboplatin, 50 mg
136 12 $99.63 $3.49
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
120 72 $203.13 $70.84
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
115 28 $149.35 $81.08
96417 Administration of additional new drug or substance into vein, 1 hour or less
110 32 $150.55 $71.82
J1200 Injection, diphenhydramine hcl, up to 50 mg
108 39 $13.00 $0.80
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
94 44 $76.91 $53.53
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
93 70 $295.70 $193.69

(top 25 shown)

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Procrit Epoetin Alfa 93 2,702 $223,346.76 15
Letrozole Letrozole 61 4,204 $1,486.50 21
Neulasta Pegfilgrastim 50 1,204 $398,671.86 11
Keytruda Pembrolizumab 49 1,029 $539,540.67 —
Xgeva Denosumab 47 1,316 $145,109.34 —
Dexamethasone Sodium Phosphate Dexamethasone Sodium Phosphate 42 954 $52.82 11
Prednisone Prednisone 31 863 $197.33 13
Eliquis Apixaban 29 1,800 $33,149.60 —
Dexamethasone Dexamethasone 29 908 $467.37 13
Hydroxyurea Hydroxyurea 25 1,616 $391.57 —
Omeprazole Omeprazole 24 1,020 $199.89 12
Oxycodone Hcl Oxycodone Hcl 23 420 $568.09 13
Ondansetron Hcl Ondansetron Hcl 20 230 $113.05 13
Darzalex Faspro Daratumumab-Hyaluronidase-Fihj 20 547 $324,661.84 —
Pemetrexed Disodium Pemetrexed Disodium 20 420 $23,575.42 —
Valacyclovir Valacyclovir Hcl 19 970 $371.61 —
Xarelto Rivaroxaban 18 900 $16,221.13 —
Lactulose Lactulose 18 227 $101.64 —
Palonosetron Hcl Palonosetron Hcl 18 387 $1,061.43 —
Zoledronic Acid Zoledronic Acid 17 453 $839.68 —
Venclexta Venetoclax 16 480 $179,104.20 —
Lupron Depot Leuprolide Acetate 15 1,332 $82,356.69 —
Revlimid Lenalidomide 14 371 $225,052.34 —
Leucovorin Calcium Leucovorin Calcium 13 364 $2,263.44 —
Carboplatin Carboplatin 13 287 $1,494.06 —

(top 25 shown)

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Specialist Primary Specialty

NUCC Taxonomy Code: 174400000X

An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: New Jersey Division of Consumer Affairs.
Look Up on State Board Site

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - HEMATOLOGY/ONCOLOGY

Medicare Enrollment ID

I20120206000757

Enrollment State Jurisdiction

NJ

PECOS Control ID

8426061482

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Medicare Group Practice Enrollments

Source: CMS Doctors and Clinicians National Downloadable File

Southern Oncology Hematology Assoc

1505 W Sherman Ave, Vineland, NJ 083607059

Phone: 8566969550

Shore Memorial Hospital

1 E New York Ave, Somers Point, NJ 082442340

Phone: 6096533500

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

6 listed
Dr. Omar Al Ustwani , MD

Internal Medicine

NPI 1275769978

Doctor of Medicine (M.D.)

Mysti Blizzard , APN

Nurse Practitioner - Family

NPI 1982117339

Advanced Practice Nurse

Lakhvir Dhaliwal

Nurse Practitioner - Family

NPI 1619634656
Dr. Benjamin Negin , MD

Internal Medicine

NPI 1366477697

Doctor of Medicine (M.D.)

Dr. Shailja Roy , MD

Internal Medicine - Hematology & Oncology

NPI 1508898594

Doctor of Medicine (M.D.)

NPI 1164413076

Doctor of Medicine (M.D.)

Career & Practice History

NPI enumerated October 31, 2005.

No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1750372686
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: October 31, 2005
Last Update: September 27, 2012
Sole Proprietor: No
Update or Correct Profile

Other Specialists in Vineland

All Specialists in Vineland

Mailing Address

1505 W Sherman Ave, Suite 101

Vineland, NJ 083606912

Phone: 8566969550

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.